Protective Effects of <i>Coptis chinensis</i> Rhizome Extract and Its Constituents (Berberine, Coptisine, and Palmatine) against α-Synuclein Neurotoxicity in Dopaminergic SH-SY5Y Cells-Reference-Cited by-同舟云学术

Protective Effects of <i>Coptis chinensis</i> Rhizome Extract and Its Constituents (Berberine, Coptisine, and Palmatine) against α-Synuclein Neurotoxicity in Dopaminergic SH-SY5Y Cells

Published:2024-04-10 Issue:4 Volume:47 Page:827-839
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Lin Chih-Hsin¹,Wu Yih-Ru¹,Chao Chih-Ying¹,Chang Kuo-Hsuan¹,Chen Chiung-Mei¹,Chen Wan-Ling¹,Yang Pei-Ning²,Lee-Chen Guey-Jen²

Affiliation:

1. Department of Neurology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine

2. School of Life Science, National Taiwan Normal University

Publisher

Pharmaceutical Society of Japan

Link

https://www.jstage.jst.go.jp/article/bpb/47/4/47_b23-00758/_pdf

Reference61 articles.

1. 1) Funayama M, Nishioka K, Li Y, Hattori N. Molecular genetics of Parkinson’s disease: contributions and global trends. J. Hum. Genet., 68, 125–130 (2023).

2. 2) Wakabayashi K, Tanji K, Odagiri S, Miki Y, Mori F, Takahashi H. The Lewy body in Parkinson’s disease and related neurodegenerative disorders. Mol. Neurobiol., 47, 495–508 (2013).

3. 3) Lwin A, Orvisky E, Goker-Alpan O, LaMarca ME, Sidransky E. Glucocerebrosidase mutations in subjects with parkinsonism. Mol. Genet. Metab., 81, 70–73 (2004).

4. 4) Mao XY, Burgunder JM, Zhang ZJ, An XK, Zhang JH, Yang Y, Li T, Wang YC, Chang XL, Peng R. Association between GBA L444P mutation and sporadic Parkinson’s disease from Mainland China. Neurosci. Lett., 469, 256–259 (2010).

5. 5) Navarro-Romero A, Fernandez-Gonzalez I, Riera J, Montpeyo M, Albert-Bayo M, Lopez-Royo T, Castillo-Sanchez P, Carnicer-Caceres C, Arranz-Amo JA, Castillo-Ribelles L, Pradas E, Casas J, Vila M, Martinez-Vicente M. Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathology. NPJ Parkinsons Dis., 8, 126 (2022).